Literature DB >> 25609071

Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease.

Jing Jin1, Qi Peng1, Zhipeng Hou2, Mali Jiang1, Xin Wang3, Abraham J Langseth4, Michael Tao1, Peter B Barker2, Susumu Mori2, Dwight E Bergles4, Christopher A Ross5, Peter J Detloff6, Jiangyang Zhang2, Wenzhen Duan7.   

Abstract

White matter abnormalities have been reported in premanifest Huntington's disease (HD) subjects before overt striatal neuronal loss, but whether the white matter changes represent a necessary step towards further pathology and the underlying mechanism of these changes remains unknown. Here, we characterized a novel knock-in mouse model that expresses mouse HD gene homolog (Hdh) with extended CAG repeat- HdhQ250, which was derived from the selective breeding of HdhQ150 mice. HdhQ250 mice manifest an accelerated and robust phenotype compared with its parent line. HdhQ250 mice exhibit progressive motor deficits, reduction in striatal and cortical volume, accumulation of mutant huntingtin aggregation, decreased levels of DARPP32 and BDNF and altered striatal metabolites. The abnormalities detected in this mouse model are reminiscent of several aspects of human HD. In addition, disturbed myelination was evident in postnatal Day 14 HdhQ250 mouse brain, including reduced levels of myelin regulatory factor and myelin basic protein, and decreased numbers of myelinated axons in the corpus callosum. Thinner myelin sheaths, indicated by increased G-ratio of myelin, were also detected in the corpus callosum of adult HdhQ250 mice. Moreover, proliferation of oligodendrocyte precursor cells is altered by mutant huntingtin both in vitro and in vivo. Our data indicate that this model is suitable for understanding comprehensive pathogenesis of HD in white matter and gray matter as well as developing therapeutics for HD.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25609071      PMCID: PMC4383863          DOI: 10.1093/hmg/ddv016

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  89 in total

1.  Quantitative neuropathological changes in presymptomatic Huntington's disease.

Authors:  E Gómez-Tortosa; M E MacDonald; J C Friend; S A Taylor; L J Weiler; L A Cupples; J Srinidhi; J F Gusella; E D Bird; J P Vonsattel; R H Myers
Journal:  Ann Neurol       Date:  2001-01       Impact factor: 10.422

Review 2.  Myelination and the trophic support of long axons.

Authors:  Klaus-Armin Nave
Journal:  Nat Rev Neurosci       Date:  2010-03-10       Impact factor: 34.870

3.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

4.  Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study.

Authors:  D Stoffers; S Sheldon; J M Kuperman; J Goldstein; J Corey-Bloom; A R Aron
Journal:  Neurology       Date:  2010-04-13       Impact factor: 9.910

5.  Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors.

Authors:  Andrea Crotti; Christopher Benner; Bilal E Kerman; David Gosselin; Clotilde Lagier-Tourenne; Chiara Zuccato; Elena Cattaneo; Fred H Gage; Don W Cleveland; Christopher K Glass
Journal:  Nat Neurosci       Date:  2014-03-02       Impact factor: 24.884

6.  Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor.

Authors:  Zachary C Baquet; Jessica A Gorski; Kevin R Jones
Journal:  J Neurosci       Date:  2004-04-28       Impact factor: 6.167

7.  [Depressive symptoms following ischemic stroke].

Authors:  Lidia Głodzik-Sobańska; Agnieszka Słowik; Anna Borratyńska; Andrzej Szczudlik
Journal:  Neurol Neurochir Pol       Date:  2003 Jan-Feb       Impact factor: 1.621

8.  Mouse Huntington's disease homolog mRNA levels: variation and allele effects.

Authors:  Karen T Dixon; Jamie A Cearley; Jesse M Hunter; Peter J Detloff
Journal:  Gene Expr       Date:  2004

9.  In vivo measurements of T1 relaxation times in mouse brain associated with different modes of systemic administration of manganese chloride.

Authors:  Yu-Ting Kuo; Amy H Herlihy; Po-Wah So; Kishore K Bhakoo; Jimmy D Bell
Journal:  J Magn Reson Imaging       Date:  2005-04       Impact factor: 4.813

10.  Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington's disease provides in vivo evidence for impaired energy metabolism.

Authors:  Simon J A van den Bogaard; Eve M Dumas; Wouter M Teeuwisse; Hermien E Kan; Andrew Webb; Raymund A C Roos; Jeroen van der Grond
Journal:  J Neurol       Date:  2011-05-26       Impact factor: 4.849

View more
  30 in total

1.  Allelic series of Huntington's disease knock-in mice reveals expression discorrelates.

Authors:  Ashish Kumar; Jennifer Zhang; Sara Tallaksen-Greene; Michael R Crowley; David K Crossman; A Jennifer Morton; Thomas Van Groen; Inga Kadish; Roger L Albin; Mathieu Lesort; Peter J Detloff
Journal:  Hum Mol Genet       Date:  2016-02-14       Impact factor: 6.150

2.  Human ESC-Derived Chimeric Mouse Models of Huntington's Disease Reveal Cell-Intrinsic Defects in Glial Progenitor Cell Differentiation.

Authors:  Mikhail Osipovitch; Andrea Asenjo Martinez; John N Mariani; Adam Cornwell; Simrat Dhaliwal; Lisa Zou; Devin Chandler-Militello; Su Wang; Xiaojie Li; Sarah-Jehanne Benraiss; Robert Agate; Andrea Lampp; Abdellatif Benraiss; Martha S Windrem; Steven A Goldman
Journal:  Cell Stem Cell       Date:  2018-12-13       Impact factor: 24.633

Review 3.  Potential Circadian Rhythms in Oligodendrocytes? Working Together Through Time.

Authors:  Christopher S Colwell; Cristina A Ghiani
Journal:  Neurochem Res       Date:  2019-03-25       Impact factor: 3.996

Review 4.  A role for autophagy in Huntington's disease.

Authors:  Katherine R Croce; Ai Yamamoto
Journal:  Neurobiol Dis       Date:  2018-08-24       Impact factor: 5.996

5.  Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease.

Authors:  Eduardo E Arteaga-Bracho; Maria Gulinello; Michael L Winchester; Nandini Pichamoorthy; Jenna R Petronglo; Alicia D Zambrano; Julio Inocencio; Chirstopher D De Jesus; Joseph O Louie; Solen Gokhan; Mark F Mehler; Aldrin E Molero
Journal:  Neurobiol Dis       Date:  2016-09-10       Impact factor: 5.996

6.  Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.

Authors:  Qian Ma; Jianmin Yang; Thomas Li; Teresa A Milner; Barbara L Hempstead
Journal:  Neurobiol Dis       Date:  2015-08-15       Impact factor: 5.996

7.  Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes.

Authors:  Biswarathan Ramani; Bharat Panwar; Lauren R Moore; Bo Wang; Rogerio Huang; Yuanfang Guan; Henry L Paulson
Journal:  Hum Mol Genet       Date:  2017-09-01       Impact factor: 6.150

8.  Inhibition of Drp1 hyperactivation reduces neuropathology and behavioral deficits in zQ175 knock-in mouse model of Huntington's disease.

Authors:  Yuanyuan Zhao; Xiaoyan Sun; Xin Qi
Journal:  Biochem Biophys Res Commun       Date:  2018-11-16       Impact factor: 3.575

Review 9.  Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells.

Authors:  Swati Naphade; Kizito-Tshitoko Tshilenge; Lisa M Ellerby
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

Review 10.  Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models.

Authors:  Jordi Creus-Muncunill; Michelle E Ehrlich
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.